CXCR4 and glioma: FTY720 could inhibit the growth, migration, and invasion of glioma by targeting GAMs to impede their effect on glioma cells, while also potentially blocking the chemoattraction of GAMs by inhibiting the MAPK-mediated secretion of IL-6 through the increased internalization of CXCR4.